9xn2: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older edit
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 9xn2 is ON HOLD  until Paper Publication
==Glucagon-like peptide 1 receptor-Gs complex activated by the small molecule agonist SIM1==
<StructureSection load='9xn2' size='340' side='right'caption='[[9xn2]], [[Resolution|resolution]] 2.61&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[9xn2]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus], [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens], [https://en.wikipedia.org/wiki/Lama_glama Lama glama] and [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9XN2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9XN2 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 2.61&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1E0Y:1-[3,5-dimethyl-4-[2-[[4-oxidanylidene-2-[4-(trifluoromethyloxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl]sulfonyl]ethyl]phenyl]pyrrolidine-2,5-dione'>A1E0Y</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9xn2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9xn2 OCA], [https://pdbe.org/9xn2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9xn2 RCSB], [https://www.ebi.ac.uk/pdbsum/9xn2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9xn2 ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/GBB1_RAT GBB1_RAT] Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The glucagon receptor (GCGR) and gastric inhibitory polypeptide receptor (GIPR) are class B GPCRs that regulate glucose homeostasis and energy balance, making them key targets for type 2 diabetes and obesity. Achieving preferential G(s) signaling at these receptors with small molecules remains an unmet challenge. Here, we report SIM1, developed through optimization of the PCO371 scaffold, which exhibits preferential G(s) signaling at GCGR and GIPR with minimal detectable beta-arrestin recruitment and substantially improved efficacy at GIPR. Cryo-EM structures of SIM1-GCGR-G(s) (2.53 A) and SIM1-GIPR-G(s) (2.74 A) reveal a shared intracellular allosteric interface at the receptor-G protein coupling region, distinct from extracellular peptide recognition. Structural comparison with GLP1R suggests that intracellular conformational constraints contribute to differential SIM1 responsiveness, which is restored by targeted mutations. Guided by these insights, analogs SIM2 and SIM3 exhibited up to 20-fold enhanced potency while maintaining an apparent preferential G(s) signaling profile. These findings reveal a conserved intracellular allosteric activation mechanism across multiple class B GPCRs and identify SIM1 and its analogs as valuable chemical tools for investigating receptor-specific intracellular allosteric regulation and G protein-preferential signaling.


Authors: Xu, H.E., Shan, H., He, Q., Zhao, L.
Structural basis for small-molecule agonism at GCGR and GIPR via a conserved intracellular allosteric site.,He Q, Shan H, Hu W, Eric Xu H, Zhao LH Acta Pharmacol Sin. 2026 Sep 14. doi: 10.1038/s41401-026-01923-5. PMID:42736455<ref>PMID:42736455</ref>


Description: Small molecule agonist bound to mutant GLP1R
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: He, Q]]
<div class="pdbe-citations 9xn2" style="background-color:#fffaf0;"></div>
[[Category: Shan, H]]
== References ==
[[Category: Xu, H.E]]
<references/>
[[Category: Zhao, L]]
__TOC__
</StructureSection>
[[Category: Bos taurus]]
[[Category: Homo sapiens]]
[[Category: Lama glama]]
[[Category: Large Structures]]
[[Category: Rattus norvegicus]]
[[Category: He Q]]
[[Category: Shan H]]
[[Category: Xu HE]]
[[Category: Zhao L]]
Retrieved from "https://proteopedia.org/9xn2"